Delivered-To: bruce@untroubled.org
Received: (fqmail 3341 invoked from network); 22 Jan 2014 16:36:56 -0000
Received: (qmail 29885 invoked from network); 22 Jan 2014 16:36:56 -0000
Received: from vld.algaliarrefloreceral.net (vld.lanka-sri.net [195.216.212.82])
  by mx10.futurequest.net ([10.2.1.182])
  with ESMTP via TCP; 22 Jan 2014 16:36:55 -0000
To: bruce@untroubled.org
Subject: PLPL to Acquire License to Diego Pellicer Brand for Cannabis Extracts
Message-ID: <d363a575c107c5502f108ae74eccd9ae@vld.algaliarrefloreceral.net>
Return-Path: enquiries@vld.algaliarrefloreceral.net
Date: Wed, 22 Jan 2014 09:46:28 -0600
From: "Biotech Penny Stock Info" <enquiries@vld.algaliarrefloreceral.net>
Reply-To: enquiries@vld.algaliarrefloreceral.net
MIME-Version: 1.0
X-Mailer-LID: 19,573
List-Unsubscribe: <http://vld.algaliarrefloreceral.net/unsubscribe.php?M=4198503&C=da3fb1d1d4bfdc21f17ccb7d32402084&L=573&N=7233>
X-Mailer-RecptId: 4198503
X-Mailer-SID: 7233
X-Mailer-Sent-By: 1
Content-Type: multipart/alternative; charset="UTF-8"; boundary="b1_b113ebbd5bf0c0fcbdcd9750ba9e5e45"
Content-Transfer-Encoding: 8bit
Content-Length: 24843

--b1_b113ebbd5bf0c0fcbdcd9750ba9e5e45
Content-Type: text/plain; format=flowed; charset="UTF-8"
Content-Transfer-Encoding: 8bit

If you would like to be removed Click here
[http://vld.algaliarrefloreceral.net/unsubscribe.php?M=4198503&C=da3fb1d1d4bfdc21f17ccb7d32402084&L=573&N=7233].

Plandai Biotechnology, Inc.
OTCQB: PLPL

Want to find out more? PLPL in the News
[http://vld.algaliarrefloreceral.net/link.php?M=4198503&N=7233&L=37&F=T]
_______________________________

Plandai Biotechnology, Inc. PLPL Executes Agreement in Anticipation of
Launching Diego Pellicer Gold(TM) Cannabinoid Extracts

Plandai Biotechnology, Inc. (OTCQB: PLPL) a producer of highly bioavailable
plant extracts for industries including health, wellness, nutraceutical,
and pharmaceutical, today announced that it has entered into an agreement
with Diego Pellicer, Inc. and Diego Pellicer Worldwide Inc. which will
permit the company use of the Diego Pellicer name for its Phytofare(TM)
cannabis extracts in medical and pharmaceutical marijuana applications.

Diego Pellicer Inc. which was cofounded by the great grandson of Diego
Pellicer, the former Vice Governor of the Island of Cebu the Philippines,
has created the most recognized brand of cannabis in the world, building on
the legacy of Vice Governor Pellicer, who was the largest grower of hemp in
the world in the late 1800s, supplying hemp rope to the Spanish Armada
during the Spanish American War.

Roger Baylis-Duffield, Chairman and Chief Executive Officer of Plandai
Biotechnology, commented, "Diego Pellicer has been the leading name in
cannabis products for over a hundred years and represents everything that
Plandai stands for from a product standpoint; namely, an exhaustive
dedication to quality. Being able to sell the Plandai cannabinoid extracts
under the Diego Pellicer name brings immediate name recognition and
branding into the medicinal cannabis industry."

The new Diego Pellicer Gold(TM) cannabinoid extracts provides for efficient
recovery of highly bioavailable and active antioxidants from live plant
materials in a mainly nano particle form. The cannabinoids, including
Î”9-THC (Delta 9-THC) and CBDs are then delivered in a Pheroid(R)-protected
state to the white cells without degradation or metabolization.

For medical and recreational applications where the metabolization of THC
is preferred, such as in treating ongoing pain, the Pheroid(R) entrapment
step will be omitted, resulting in a highly bioavailable cannabinoid
extract that will conclude in significantly lower required dosages. Plandai
anticipates producing both capsules and cannabis oil (for vapor use) in
Pheroid(TM) and non-Pheroid(TM) versions with the immediate aim of
generating nutraceutical sales while pursuing eventual FDA clearance for
pharmaceutical applications.

Jamen Shively, co-founder of Diego Pellicer, added, "We couldn't be happier
with our partnership with Plandai. Their Phytofare(TM) technology appears
to be years ahead of the competition as it relates to bioavailability and
will help anchor the Diego brand as more states legalize cannabis for
medical and/or recreational applications. Plandai can provide
pharmaceutical-grade extracts, with or without psychoactive properties,
that will significantly lower costs to the end customer, which is
critically important for medical cannabis, as well as provide superior
products. In addition, adverse side effects and risks of overconsumption
will be greatly mitigated, by providing higher purity, with substantially
lower dosage requirements for achieving a desired outcome."

About Plandai Biotechnology, Inc.

Plandai Biotechnology, Inc. and its subsidiaries develop highly
bioavailable, phytonutrient rich extracts which are being utilized to
deliver a new family of drugs to safely and affordably treat a multitude of
diseases and conditions. Plandai Biotechnology controls every aspect of the
process, from growing the raw materials on its farms in South Africa, to
producing its patented Phytofare(TM) extracts in-house, allowing the
Company to confirm the continuity of supply as well as quality control
throughout the entire process. Targeted industries for the Company's
products include beverage, cosmeceutical, wellness, nutraceutical,
anti-aging, and pharmaceutical. For more information, please go to
http://vld.algaliarrefloreceral.net/link.php?M=4198503&N=7233&L=62&F=T.

_______________________

The use of research materials distributed by the author is done at your own
risk. You are encouraged to do your own research before making any
investment decision in regards to the public company discussed herein. The
author has not been remunerated by any entity in connection with the
disbursement of these materials. You should presume that as of the date of
this report or letter, the author, possibly along with or through our
owners, affiliates, employees and/or consultants, (communally referred to
as the author) has a position in all company shares (and/or options of the
shares) covered herein that is consistent with the position set forth in
our report. In connection with PLPL, the author has taken a long position.
Following the distribution of any report or letter, the author intends to
continue engaging in transactions in the public company covered herein, and
we may be long, short, and/or neutral at any time hereafter regardless of
our initial position and we preserve the right to procure or trade all or
part of our position at any time without notice. This practice could end in
our trading position at any time before, during, and/or after the
disbursement of this report.

All rights reserved. The Stock Co.

You are receiving this email because you have been subscribed to our
newsletter list. If you do not wish to receive our newsletter emails in the
future, please unsubscribe
[http://vld.algaliarrefloreceral.net/unsubscribe.php?M=4198503&C=da3fb1d1d4bfdc21f17ccb7d32402084&L=573&N=7233]

--b1_b113ebbd5bf0c0fcbdcd9750ba9e5e45
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: 8bit

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<title>Plaindai Biotechnology (PLPL)</title>
<style type="text/css">

	body margin:0; padding:0; background-color:#444444; color:#777777;
font-family:Arial, Helvetica, sans-serif; font-size:12px;
-webkit-text-size-adjust:100%; -ms-text-size-adjust:100%; width:100%
!important; text-align:center;
	a, a:link, a:visited color:#0c87c7; text-decoration:underline;
	a:hover, a:active text-decoration:none; color:#006ca4 !important;
	h1, h2 color:#333333 !important; padding:0px 0px 10px 0px; margin:0px 0px
10px 0px;
	p margin:0 0 14px 0; padding:0;
	img border:0; -ms-interpolation-mode: bicubic; max-width:100%;
	a img border:none;
	table td border-collapse:collapse;
	.highlighted color:#0c87c7;

	/* Clients specific styles */
	.ReadMsgBody width: 100%;
	.ExternalClass width: 100%;
	.yshortcuts color: #777777;
	.yshortcuts a span color: #777777; border-bottom: none !important;
background: none !important; text-decoration:none !important;
	/* / Clients specific styles */

	/* Media queries */
	@media only screen and (max-width: 640px)
		table[class=row] {width:580px !important;
		img[class=wideImage], img[class=banner] width:100% !important;
height:auto !important; max-width:100%;
	}
	@media only screen and (max-width: 610px)
		table[class=row] {width:570px !important;
		td[class=container] padding:0px !important;
	}
	@media only screen and (max-width: 540px)
		table[class=row] {width:510px !important;
		td[class=oneFromFour] font-size:14px !important; line-height:15pt
!important;
	}
	@media only screen and (max-width: 480px)
		table[class=row] {width:450px !important;
		td[class=oneFromTwo], td[class=twoColumns] display:block; width:100%
!important; padding-right:0px !important; padding-left:0px !important;
		td[class=column] display:block; width:390px !important;
padding-right:30px !important; padding-left:30px !important;
		td[class=website] display:block; width:390px !important; padding:15px
30px 15px 30px !important; text-align:center;
		td[class=socialIcons] display:block; width:390px !important; padding:0px
30px 15px 30px !important; text-align:center !important;
		img[class=phoneIcon] display:none !important;
		img[class=wideImage] width:auto !important;
		table[class=quoteContainer] width:190px !important;
	}
	@media only screen and (max-width: 360px)
		table[class=row] {width:340px !important;
		td[class=column], td[class=website], td[class=socialIcons] width:280px
!important;
		td[class=logo] display:block; width:280px !important; padding-bottom:30px
!important; padding-right:30px !important; padding-left:30px !important;
		td[class=phone] display:block; width:280px !important; padding:9px 30px
13px 30px !important; text-align:left !important;
background-color:#f4f4f4;
		td[class=phone2] display:block; width:280px !important; padding:8px 30px
8px 30px !important; text-align:left !important; border-top:1px solid
#f4f4f4;
		div[class=phoneNumber] display:inline-block; margin-left:3px !important;
font-size:12px !important; line-height:100% !important;
		div[class=phoneNumber] img.vspace display:none !important;
		td[class=icon] padding-top:10px !important; padding-bottom:10px
!important;
		table[class=quoteContainer] width:140px !important;
		table[class=quoteContainer] td font-size:12px !important;
line-height:15pt !important;
		td[class=footer] padding:0px 0px 25px 0px !important; text-align:left
!important;
	}
	@media only screen and (max-width: 320px)
		table[class=row] {width:300px !important;
		td[class=column], td[class=website], td[class=socialIcons],
td[class=logo], td[class=phone], td[class=phone2] width:240px !important;
		table[class=quoteContainer] width:100% !important; border-bottom:1px
solid #eeeeee; margin-bottom:20px;
		table[class=quoteContainer] td padding-left:0px !important;
		td[class=quoteAuthor] padding-bottom:20px !important;
	}
	@media only screen and (max-width: 240px)
		table[class=row] {width:220px !important;
		td[class=column], td[class=logo], td[class=phone], td[class=phone2]
width:160px !important;
		td[class=oneFromFour] display:block; width:100% !important;
padding-right:0px !important; padding-left:0px !important;
		td[class=website], td[class=socialIcons] width:220px !important;
padding-right:0px !important; padding-left:0px !important;
		td[class=website] font-size:18px !important;
		img[class=wideImage] width:100% !important;
		table[class=iconContainer], table[class=imgContainer] width:100%
!important;
		td[class=icon], td[class=authorPicture] padding-right:0px !important;
padding-bottom:20px !important; text-align:center;
		td[class=icon] img, td[class=authorPicture] img display:inline
!important;
	}
	/* / Media queries */

</style>

<!-- Internet Explorer fix -->
<!--[if IE]>
<style type="text/css">
@media only screen and (max-width: 480px)
    td[class=oneFromTwo], td[class=twoColumns], td[class=column],
td[class=website], td[class=socialIcons] {float:left;
}
@media only screen and (max-width: 360px)
    td[class=logo], td[class=phone], td[class=phone2] {float:left;
    div[class=phoneNumber] display:block !important; margin-left:0px
!important;
    div[class=phoneNumber] a, div[class=phoneNumber] span  display:block;
margin:0; padding:0; text-decoration:none;
}
</style>
<![endif]-->
<!-- / Internet Explorer fix -->

<!-- Windows Mobile 7 fix -->
<!--[if IEMobile 7]>
<style type="text/css">
    td[class=container] padding:0px !important;
    table[class=row] width:450px !important;
    td[class=oneFromTwo], td[class=twoColumns] display:block; float:left;
width:100% !important; padding-right:0px !important; padding-left:0px
!important;
    td[class=oneFromFour] font-size:14px !important; line-height:15pt
!important;
    td[class=column] display:block; float:left; width:390px !important;
padding-right:30px !important; padding-left:30px !important;
    td[class=website] display:block; float:left; width:390px !important;
padding:15px 30px 15px 30px !important; text-align:center;
    td[class=socialIcons] display:block; float:left; width:390px
!important; padding:0px 30px 15px 30px !important; text-align:center
!important;
    img[class=phoneIcon] display:none !important;
    table[class=quoteContainer] width:190px !important;
</style>
<![endif]-->
<!-- / Windows Mobile 7 fix -->

<!-- Outlook 2013 fix -->
<!--[if gte mso 15]>
<style type="text/css">
 .iconContainer, .quoteContainer mso-table-rspace:0px; border-right:1px
solid #ffffff;
 .imgContainer mso-table-rspace:0px; border-right:1px solid #f4f4f4;
</style>
<![endif]-->
<!-- / Outlook 2013 fix -->

</head>

<body>
<table cellpadding="0" cellspacing="0" border="0" align="center"
style="border-collapse: collapse; background-color: #444444; width:
100%;">
<tbody>
<tr>
<td class="container" style="padding-left: 15px; padding-right: 15px;"><!--
Start of logo, phone and banner -->
<table class="row" bgcolor="#ffffff" align="center" cellpadding="0"
cellspacing="0" border="0" style="border-collapse: collapse; text-align:
left; border-spacing: 0px; max-width: 100%; width: 610px;">
<tbody>
<tr>
<td width="100%" colspan="2" bgcolor="#444444" style="padding-top: 30px;
padding-bottom: 5px; font-family: Arial, Helvetica, sans-serif; font-size:
11px; line-height: 100%; color: #aaaaaa; text-align: right;
-webkit-text-size-adjust: none;">If you would like to be removed&nbsp;<a
style="text-decoration: underline; color: #0c87c7;"
href="http://vld.algaliarrefloreceral.net/unsubscribe.php?M=4198503&C=da3fb1d1d4bfdc21f17ccb7d32402084&L=573&N=7233">Click
here</a>.</td>
</tr>
<tr>
<td width="60%" height="5" valign="top" style="font-size: 2px; line-height:
0px;"></td>
<td width="40%" height="5" valign="top" style="font-size: 2px; line-height:
0px;"></td>
</tr>
<tr>
<td width="100%" colspan="2">
<table cellpadding="0" cellspacing="0" border="0" style="border-collapse:
collapse; text-align: left; border-spacing: 0px; max-width: 100%;
font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height:
100%; color: #777777; width: 100%;">
<tbody>
<tr>
<td class="logo" width="60%" style="padding-top: 25px; padding-right: 15px;
padding-bottom: 30px; padding-left: 30px; font-family: 'Segoe UI',
'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 24px;
line-height: 100%; color: #3b9b04; font-weight: normal; text-align:
center;">
<div style="margin-top: 0px; margin-bottom: 0px !important; padding: 0px;
line-height: 100%; text-align: center;">Plandai Biotechnology, Inc.<br
/>OTCQB: <strong>PLPL</strong></div>
</td>
<td class="phone" width="40%" style="padding-top: 17px; padding-right:
30px; padding-bottom: 22px; padding-left: 15px; font-family: Arial,
Helvetica, sans-serif; font-size: 12px; line-height: 100%; color: #777777;
text-align: right;">Want to find out more?
<div class="phoneNumber" style="margin-top: 0px; margin-bottom: 0px;
padding: 0px; font-size: 24px; line-height: 24px; font-weight: 300; color:
#777777; font-family: 'Segoe UI', 'Helvetica Neue', Helvetica, Arial,
sans-serif;"><a
href="http://vld.algaliarrefloreceral.net/link.php?M=4198503&N=7233&L=37&F=H"
target="_blank">PLPL in the News</a></div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="100%" colspan="2" style="font-family: Arial, Helvetica,
sans-serif; font-size: 12px; line-height: 100%; text-align: center; color:
#0c87c7;">&nbsp;</td>
</tr>
<tr>
<td width="100%" colspan="2" bgcolor="#444444" valign="top"
style="padding-bottom: 20px; font-size: 2px; line-height: 0px; text-align:
center;">&nbsp;</td>
</tr>
</tbody>
</table>
<!-- End of logo, phone and banner --> <!-- Start of text with icon on the
left -->
<table class="row" bgcolor="#ffffff" align="center" cellpadding="0"
cellspacing="0" border="0" style="border-collapse: collapse; text-align:
left; border-spacing: 0px; max-width: 100%; width: 610px;">
<tbody>
<tr>
<td width="100%" colspan="2" style="padding-top: 15px; padding-right: 30px;
padding-bottom: 10px; padding-left: 30px;">
<h2 style="margin-top: 0px; margin-bottom: 10px !important; padding-top:
0px; padding-bottom: 10px; font-family: 'Segoe UI', 'Helvetica Neue',
Helvetica, Arial, sans-serif; font-size: 20px; line-height: 22pt; color:
#333333; font-weight: normal; border-bottom: 1px; border-bottom-color:
#eeeeee; border-bottom-style: solid;">Plandai Biotechnology,
Inc.&nbsp;<span class="highlighted" style="color: #3b9b04; font-weight:
bold;">PLPL</span>&nbsp;Executes Agreement in Anticipation of Launching
Diego Pellicer Gold(TM) Cannabinoid Extracts</h2>
</td>
</tr>
<tr>
<td width="100%" colspan="2" style="padding-right: 30px; padding-bottom:
25px; padding-left: 30px; font-family: Arial, Helvetica, sans-serif;
font-weight: normal; font-size: 14px; line-height: 15pt; color:
#777777;"><strong>Plandai Biotechnology, Inc. (OTCQB: PLPL)</strong> a
producer of highly bioavailable plant extracts for industries including
health, wellness, nutraceutical, and pharmaceutical, today announced that
it has entered into an agreement with Diego Pellicer, Inc. and Diego
Pellicer Worldwide Inc. which will permit the company use of the Diego
Pellicer name for its Phytofare(TM) cannabis extracts in medical and
pharmaceutical marijuana applications. <br /><br /> Diego Pellicer Inc.
which was cofounded by the great grandson of Diego Pellicer, the former
Vice Governor of the Island of Cebu the Philippines, has created the most
recognized brand of cannabis in the world, building on the legacy of Vice
Governor Pellicer, who was the largest grower of hemp in the world in the
late 1800s, supplying hemp rope to the Spanish Armada during the Spanish
American War. <br /><br /> Roger Baylis-Duffield, Chairman and Chief
Executive Officer of Plandai Biotechnology, commented, "Diego Pellicer has
been the leading name in cannabis products for over a hundred years and
represents everything that Plandai stands for from a product standpoint;
namely, an exhaustive dedication to quality. Being able to sell the Plandai
cannabinoid extracts under the Diego Pellicer name brings immediate name
recognition and branding into the medicinal cannabis industry." <br /><br
/> The new Diego Pellicer Gold(TM) cannabinoid extracts provides for
efficient recovery of highly bioavailable and active antioxidants from live
plant materials in a mainly nano particle form. The cannabinoids, including
&Delta;9-THC (Delta 9-THC) and CBDs are then delivered in a
Pheroid(R)-protected state to the white cells without degradation or
metabolization. <br /><br /> For medical and recreational applications
where the metabolization of THC is preferred, such as in treating ongoing
pain, the Pheroid(R) entrapment step will be omitted, resulting in a highly
bioavailable cannabinoid extract that will conclude in significantly lower
required dosages. Plandai anticipates producing both capsules and cannabis
oil (for vapor use) in Pheroid(TM) and non-Pheroid(TM) versions with the
immediate aim of generating nutraceutical sales while pursuing eventual FDA
clearance for pharmaceutical applications. <br /><br /> Jamen Shively,
co-founder of Diego Pellicer, added, "We couldn't be happier with our
partnership with Plandai. Their Phytofare(TM) technology appears to be
years ahead of the competition as it relates to bioavailability and will
help anchor the Diego brand as more states legalize cannabis for medical
and/or recreational applications. Plandai can provide pharmaceutical-grade
extracts, with or without psychoactive properties, that will significantly
lower costs to the end customer, which is critically important for medical
cannabis, as well as provide superior products. In addition, adverse side
effects and risks of overconsumption will be greatly mitigated, by
providing higher purity, with substantially lower dosage requirements for
achieving a desired outcome." <br /><br /> About Plandai Biotechnology,
Inc. <br /><br /> Plandai Biotechnology, Inc. and its subsidiaries develop
highly bioavailable, phytonutrient rich extracts which are being utilized
to deliver a new family of drugs to safely and affordably treat a multitude
of diseases and conditions. Plandai Biotechnology controls every aspect of
the process, from growing the raw materials on its farms in South Africa,
to producing its patented Phytofare(TM) extracts in-house, allowing the
Company to confirm the continuity of supply as well as quality control
throughout the entire process. Targeted industries for the Company's
products include beverage, cosmeceutical, wellness, nutraceutical,
anti-aging, and pharmaceutical. For more information, please go to
http://www.plandaibiotech.com.</td>
</tr>
<tr>
<td width="50%" height="5" valign="bottom" style="font-size: 2px;
line-height: 0px;"></td>
<td width="50%" height="5" valign="bottom" style="font-size: 2px;
line-height: 0px;"></td>
</tr>
<tr>
<td width="100%" colspan="2" bgcolor="#444444" valign="top"
style="padding-bottom: 20px; font-size: 2px; line-height: 0px; text-align:
center;">&nbsp;</td>
</tr>
</tbody>
</table>
<!-- End of text with icon on the left --> <!-- Start of text with icon on
the left --><!-- End of text with icon on the left --> <!-- Start of text
with icon on the left -->
<table class="row" bgcolor="#ffffff" align="center" cellpadding="0"
cellspacing="0" border="0" style="border-collapse: collapse; text-align:
left; border-spacing: 0px; max-width: 100%; width: 610px;">
<tbody>
<tr>
<td width="100%" height="5" valign="top" style="font-size: 2px;
line-height: 0px;"></td>
<td width="100%" height="5" valign="top" style="font-size: 2px;
line-height: 0px;"></td>
</tr>
<tr>
<td width="100%" colspan="2" style="padding-right: 30px; padding-bottom:
25px; padding-left: 30px; font-family: Arial, Helvetica, sans-serif;
font-weight: normal; font-size: 12px; line-height: 15pt; color:
#777777;">The use of research materials distributed by the author is done
at your own risk. You are encouraged to do your own research before making
any investment decision in regards to the public company discussed herein.
The author has not been remunerated by any entity in connection with the
disbursement of these materials. You should presume that as of the date of
this report or letter, the author, possibly along with or through our
owners, affiliates, employees and/or consultants, (communally referred to
as the author) has a position in all company shares (and/or options of the
shares) covered herein that is consistent with the position set forth in
our report. In connection with PLPL, the author has taken a long position.
Following the distribution of any report or letter, the author intends to
continue engaging in transactions in the public company covered herein, and
we may be long, short, and/or neutral at any time hereafter regardless of
our initial position and we preserve the right to procure or trade all or
part of our position at any time without notice. This practice could end in
our trading position at any time before, during, and/or after the
disbursement of this report.<br /><a href="#"></a></td>
</tr>
<tr>
<td width="100%" height="5" valign="bottom" style="font-size: 2px;
line-height: 0px;"></td>
<td width="100%" height="5" valign="bottom" style="font-size: 2px;
line-height: 0px;"></td>
</tr>
<tr>
<td width="100%" colspan="2" bgcolor="#444444" valign="top"
style="padding-bottom: 20px; font-size: 2px; line-height: 0px; text-align:
center;">&nbsp;</td>
</tr>
</tbody>
</table>
<!-- End of text with icon on the left --> <!-- Start of footer -->
<table class="row" bgcolor="#ffffff" align="center" cellpadding="0"
cellspacing="0" border="0" style="border-collapse: collapse; text-align:
left; border-spacing: 0px; max-width: 100%; width: 610px;">
<tbody>
<tr>
<td class="footer" width="100%" colspan="2" bgcolor="#444444"
style="padding: 0px 30px 25px 30px; font-family: Arial, Helvetica,
sans-serif; font-size: 11px; line-height: 13pt; color: #aaaaaa; text-align:
center; -webkit-text-size-adjust: none;">All rights reserved. The Stock
Co.<br /> You are receiving this email because you have been subscribed to
our newsletter list. If you do not wish to receive our newsletter emails in
the future, please <a style="text-decoration: underline; color: #0c87c7;"
href="http://vld.algaliarrefloreceral.net/unsubscribe.php?M=4198503&C=da3fb1d1d4bfdc21f17ccb7d32402084&L=573&N=7233">unsubscribe</a>
here.</td>
</tr>
</tbody>
</table>
<!-- End of footer --></td>
</tr>
</tbody>
</table>
<img
src="http://vld.algaliarrefloreceral.net/open.php?M=4198503&L=573&N=7233&F=H&image=.jpg"
height="1" width="10"></body>
</html>

--b1_b113ebbd5bf0c0fcbdcd9750ba9e5e45--
